EUVIMEDEUVIMED entdecken
Crossref

Association of TNFRSF13B Gene Polymorphisms With SARS‐CoV‐2 Infection, Severity, and Humoral Immune Response in a Moroccan Population

Oumaima Laazaazia, Ahd Ouladlahsen, Safaa Aqillouch, Haya Altawalah, Oumaima Bouddahab, Rachid Noureddine, Pascal Pineau, Mustapha Lkhider, Sayeh Ezzikouri iD

International Journal of Immunogenetics · 2025-04 · 52 (2) · 75-87

DOI: 10.1111/iji.12709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunogenetics, online erschienen am 02.03.2025. Verfasst von Oumaima Laazaazia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco. Hauptthemen laut MEDLINE: COVID-19, Immunity, Humoral, Polymorphism, Single Nucleotide, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: ACIP, Institut Pasteur, Taskforce COVID-19 of Institut Pasteur.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Genetic factors, including polymorphisms in the TNFRSF13B gene, which regulates humoral immunity, can influence susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). This study aims to investigate the association between two polymorphisms, rs12603708 and rs3751987, and SARS‐CoV‐2 susceptibility, disease severity, and humoral immune responses in a Moroccan population. Materials and Methods: A total of 303 unvaccinated COVID‐19 patients (151 severe cases and 152 asymptomatic/moderate cases) and 150 individuals from a SARS‐CoV‐2‐negative group were included in the analysis. Genotyping was performed using TaqMan SNP assays. SARS‐CoV‐2 antibodies targeting the nucleocapsid protein and IgG antibodies specific to the receptor‐binding domain (RBD) were quantified using chemiluminescence microparticles immunoassay. Complete blood counts and C‐reactive protein levels were evaluated using an automated platform.

Results

Our analysis revealed that the A/A genotype of rs12603708 significantly increased the risk of SARS‐CoV‐2 infection in both codominant ( p = 0.0055; OR = 3.74; adjusted p value = 0.022) and recessive ( p = 0.0049; OR = 3.17; adjusted p value = 0.022) models, as well as the risk of severe disease ( p = 0.014; OR = 3.43; adjusted p value = 0.049). For rs3751987, the G/G genotype was linked to higher susceptibility to infection ( p = 0.0011; OR = 2.91; adjusted p value = 0.008), while the G/A genotype appeared protective ( p = 0.0007; OR = 0.45; adjusted p value = 0.008). No association was found between rs3751987 and disease severity. Analysis of IgG anti‐N and anti‐RBD levels revealed no significant associations with either polymorphism ( p > 0.05).

Conclusion

These findings highlight the role of TNFRSF13B polymorphisms in SARS‐CoV‐2 susceptibility and severity, while their impact on humoral immune responses appears limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Immunity, HumoralPolymorphism, Single NucleotideSARS-CoV-2HumansMoroccoMaleFemaleMiddle AgedAdultGenetic Predisposition to DiseaseSeverity of Illness IndexGenotypeAntibodies, ViralAgedImmunoglobulin G

Stichwörter der Autor:innen

COVID‐19SNPTNFRSF13Bimmune humoral responsesusceptibility

Substanzen

Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
  • Laboratory of Virology, Microbiology, Quality and Biotechnology/Ecotoxicology and Biodiversity, Hassan II University, Faculté des Sciences et Techniques, Mohammedia, Morocco.
  • Service des maladies Infectieuses, CHU Ibn Rochd, Casablanca, Morocco.
  • Department of Microbiology, Faculty of Medicine, Kuwait University, Safat, Kuwait.
  • Virology Unit, Yacoub Behbehani Center, Sabah Hospital, Ministry of Health, Shuwaikh, Kuwait.
  • Institut Pasteur, Université Paris Cité, Unité « Organisation Nucléaire et Oncogenèse», INSERM U993, Paris, France.

ORCID-Profile: Sayeh Ezzikouri

Förderung

  • ACIP
  • Institut Pasteur
  • Taskforce COVID-19 of Institut Pasteur
  • Scientific and Technological Research Program related to COVID-19

Zitieren

APA

Laazaazia, O., Ouladlahsen, A., Aqillouch, S., Altawalah, H., Bouddahab, O., Noureddine, R., Pineau, P., Lkhider, M., & Ezzikouri, S. (2025). Association of TNFRSF13B Gene Polymorphisms With SARS‐CoV‐2 Infection, Severity, and Humoral Immune Response in a Moroccan Population. International Journal of Immunogenetics, 52(2), 75-87. https://doi.org/10.1111/iji.12709

Vancouver

Laazaazia O, Ouladlahsen A, Aqillouch S, Altawalah H, Bouddahab O, Noureddine R, et al. Association of TNFRSF13B Gene Polymorphisms With SARS‐CoV‐2 Infection, Severity, and Humoral Immune Response in a Moroccan Population. International Journal of Immunogenetics. 2025;52(2):75-87. doi:10.1111/iji.12709

BibTeX
@article{Laazaazia2025,
  author = {Laazaazia, Oumaima and Ouladlahsen, Ahd and Aqillouch, Safaa and Altawalah, Haya and Bouddahab, Oumaima and Noureddine, Rachid and Pineau, Pascal and Lkhider, Mustapha and Ezzikouri, Sayeh},
  title = {Association of TNFRSF13B Gene Polymorphisms With SARS‐CoV‐2 Infection, Severity, and Humoral Immune Response in a Moroccan Population},
  journal = {International Journal of Immunogenetics},
  year = {2025},
  volume = {52},
  number = {2},
  pages = {75--87},
  doi = {10.1111/iji.12709}
}
Kostenlos starten →